ask="2.35"
ask_size="500"
average_daily_volume="1260350"
bid="2.20"
bid_size="2000"
book_value="1.72"
change="-0.05"
change_from_200_day_moving_average="-0.59"
change_from_50_day_moving_average="0.11"
change_from_52_week_high="-3.67"
change_From_52_week_low="2.05"
change_in_percent="-2.13%"
close="2.30"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.25"
ebitda="-3.16M"
eps_estimate_current_year="-1.75"
eps_estimate_next_quarter="0.00"
eps_estimate_next_year="-1.85"
ex_dividend_date="N/A"
float_shares="7579000"
high="2.37"
high_52_weeks="5.97"
last_trade_date="1/10/2017"
last_trade_price="2.30"
last_trade_size="100"
last_trade_time="3:59pm"
low="2.16"
low_52_weeks="0.25"
market_capitalization="35.40M"
moving_average_200_day="2.89"
moving_average_50_day="2.19"
name="Eleven Biotherapeutics
Inc."
notes="N/A"
one_year_target_price="12.00"
open="2.35"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-20.52%"
percent_change_from_50_day_moving_average="+5.10%"
percent_change_from_52_week_high="-61.47%"
percent_change_from_52_week_low="+815.97%"
previous_close="2.35"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.37"
price_per_sales="1.22"
revenue="29.72M"
shares_outstanding="15393000"
short_ratio="1.80"
stock_exchange="NGM"
symbol="EBIO"
volume="630009"
weeks_range_52="0.25 - 5.97"
